MRSA and How Staph Became Resistant to Antibiotics (Video)
Written guide: mrsA Gene: Structure, Function, and Clinical Significance
This video explains how methicillin-resistant Staphylococcus aureus (MRSA) became resistant to beta-lactam antibiotics and how laboratories identify it.
Chapters
- 0:00 Introduction
- 1:03 What MRSA is
- 1:44 How Staphylococcus aureus causes infection
- 2:39 Penicillin and the first resistance
- 3:24 Methicillin and the name MRSA
- 4:09 How MRSA resists beta-lactams
- 5:03 Hospital and community MRSA
- 6:02 How laboratories identify MRSA
- 6:38 Treatment
- 7:44 The global burden
- 8:23 Prevention
- 9:10 Review and question
Video transcript
0:00 Introduction
In this lesson, we will learn about MRSA, a group of Staphylococcus aureus strains that resist common antibiotics and directly caused more than 100,000 deaths worldwide in 2019, how these strains became resistant, and how doctors treat and prevent their infections. MRSA stands for methicillin-resistant Staphylococcus aureus, a group of Staphylococcus aureus strains that resist methicillin and nearly all other beta-lactam antibiotics, the large class of drugs that includes penicillin. First, we will look at the bacterium itself and at the infections it causes, and then we will follow the history of penicillin and methicillin that led to resistance. After the history, we will look at the gene that makes MRSA resistant and at the places where MRSA spreads, and then at the tests that laboratories use to identify the bacterium. In the last part of the lesson, we will cover treatment, the global number of deaths, and the measures that prevent spread.
1:03 What MRSA is
To understand MRSA, we first need to know the species it belongs to. Staphylococcus aureus is a Gram-positive bacterium, so it stains purple in the Gram stain, and its round cells, called cocci, grow in clusters that resemble bunches of grapes. According to the CDC, about a third of people carry Staphylococcus aureus in the nose, and about two in 100 people carry MRSA. Most people who carry the bacterium never become ill, because the bacteria live on the skin and in the nose without entering the tissue beneath. Microbiologists call this state colonization, and they reserve the word infection for bacteria that invade tissue and cause disease.
1:44 How Staphylococcus aureus causes infection
Colonization becomes infection when the bacteria get past the skin, so the next question is how they do that and what disease follows. The bacteria enter through cuts, wounds, surgical incisions and medical devices such as catheters, which are thin tubes placed in a vein or in the bladder. Most infections stay in the skin and soft tissue, where they form boils and abscesses, which are red, swollen and painful collections of pus. When the bacteria spread beyond the skin, they cause invasive infections, including bacteremia, which means bacteria in the blood, pneumonia, endocarditis, which is infection of the heart valves, and osteomyelitis, which is infection of bone. These invasive infections can be fatal, and Staphylococcus aureus makes them worse with toxins that kill white blood cells and enzymes that help the bacteria spread through tissue.
2:39 Penicillin and the first resistance
Since doctors treat these infections with antibiotics, the story of resistance begins with penicillin. Penicillin and the other beta-lactam antibiotics bind penicillin-binding proteins, or PBPs, which are the enzymes that cross-link peptidoglycan, the mesh that gives the bacterial cell wall its strength. Without new cross-links, a growing cell cannot repair its wall, so the wall weakens and the cell bursts. Within a few years of the wide use of penicillin in the 1940s, many hospital strains of Staphylococcus aureus began to produce penicillinase, an enzyme that cuts the beta-lactam ring and inactivates the drug. By the 1950s, most hospital strains had become resistant to penicillin.
3:24 Methicillin and the name MRSA
To get around penicillinase, chemists modified the penicillin molecule, and the new drug, methicillin, later gave MRSA its name. Methicillin is a penicillin that chemists modified in the laboratory, and its bulky side chain keeps penicillinase from breaking its beta-lactam ring, and it was introduced in Britain in 1959 under the trade name Celbenin. In January 1961, less than two years later, Patricia Jevons reported methicillin-resistant strains of Staphylococcus aureus in a letter to the British Medical Journal. Methicillin is no longer used to treat patients, and laboratories now test resistance with oxacillin or cefoxitin, but the name MRSA has remained.
4:09 How MRSA resists beta-lactams
Methicillin resists penicillinase, so the resistant strains that Jevons reported must have used a different mechanism, and that mechanism depends on a gene called mecA. The mecA gene encodes an extra penicillin-binding protein, PBP2a, which binds beta-lactam antibiotics only weakly. While the drug blocks the normal PBPs, PBP2a goes on cross-linking peptidoglycan, so the cell wall stays intact and the bacterium keeps growing. For this reason, MRSA resists penicillins, cephalosporins such as cefazolin, and carbapenems, and the fifth-generation cephalosporin ceftaroline is an exception because it binds PBP2a. The mecA gene sits on a mobile stretch of DNA called the staphylococcal cassette chromosome mec, or SCCmec, which can pass between staphylococci, and a related gene, mecC, gives the same resistance in some strains.
5:03 Hospital and community MRSA
After methicillin resistance appeared, MRSA spread first in hospitals and later in the community, and doctors still classify MRSA into two groups by where the infection began. Healthcare-associated MRSA infects patients in hospitals and nursing homes, especially after surgery and in patients with catheters, ventilators or dialysis. Community-associated MRSA appeared in the 1990s in healthy people outside hospitals, mostly as skin infections, and it spreads among athletes, prisoners and military recruits, who share close contact and equipment. In the United States, the USA300 strain has been the most common community strain, and many community strains make Panton-Valentine leukocidin, a toxin that kills white blood cells. In both settings, MRSA spreads by direct skin contact and by shared objects such as towels and razors, and in hospitals it travels on the hands of health workers.
6:02 How laboratories identify MRSA
Because MRSA looks the same as other Staphylococcus aureus under the microscope, the diagnosis depends on laboratory tests. The laboratory grows the bacteria from a sample of the wound, the blood or the sputum and identifies the species. A susceptibility test then shows whether the strain grows in the presence of cefoxitin or oxacillin, and growth marks the strain as MRSA. Rapid tests based on the polymerase chain reaction, or PCR, detect the mecA gene directly within hours, and nasal swabs screen patients for carriage before surgery or on admission to hospital.
6:38 Treatment
With the diagnosis made, treatment depends on where the infection is and how severe it is. Doctors usually treat a small skin abscess by cutting it open and draining the pus, and they add an antibiotic for larger or spreading infections. For skin infections, oral options include trimethoprim-sulfamethoxazole, doxycycline, clindamycin and linezolid, and the susceptibility test decides which of these drugs to use. Serious infections need intravenous vancomycin, or daptomycin for bloodstream infections, with linezolid and ceftaroline as alternatives, and doctors do not use daptomycin for pneumonia because surfactant, the fatty film that lines the air sacs of the lungs, inactivates the drug. Vancomycin also blocks cell wall synthesis, but it binds the D-alanyl-D-alanine end of the peptidoglycan building block instead of a PBP, so PBP2a gives no protection against vancomycin. Strains with reduced vancomycin susceptibility, called VISA, do occur, and fully vancomycin-resistant strains, called VRSA, are rare.
7:44 The global burden
Even with these treatments, MRSA remains a major cause of death, and two global studies have estimated how many people it killed in a single year. The Global Research on Antimicrobial Resistance study, published in The Lancet in 2022, estimated that MRSA directly caused more than 100,000 deaths worldwide in 2019, more than any other single combination of bacterium and resistant drug. A follow-up study in 2024 estimated about 130,000 deaths directly caused by MRSA in 2021, up from about 57,000 in 1990.
8:23 Prevention
Because some patients die even with treatment, hospitals and households also work to stop MRSA from spreading. Hand hygiene with soap and water or an alcohol rub is the main measure, both in hospitals and at home. Hospitals add contact precautions with gloves and gowns, screening of high-risk patients, and cleaning of shared equipment. Before some operations, mupirocin ointment in the nose and chlorhexidine body washes remove the bacteria from carriers and lower the risk of infection. Antibiotic stewardship, which means giving antibiotics only when needed and at the right dose, slows the selection of resistant strains. At home, covering wounds and not sharing towels or razors lowers the risk of passing MRSA from one person to another.
9:10 Review and question
Here is a summary of what we covered. MRSA is Staphylococcus aureus that carries mecA, or less often mecC, and the PBP2a enzyme that mecA encodes keeps building the cell wall when beta-lactam drugs block the normal enzymes. Resistance to methicillin appeared less than two years after the drug was introduced, and MRSA now spreads both in hospitals and among healthy people in the community. Laboratories confirm MRSA with cefoxitin or oxacillin testing or with PCR for mecA, doctors treat it with drainage and drugs such as vancomycin, and hand hygiene and careful antibiotic use limit its spread. Here is a question for you. A laboratory tests a patient's MRSA isolate against ceftaroline and against cefazolin, an older cephalosporin. Which drug is more likely to work, and why? Please write your answer in the comments below.